Global Naproxen Active Pharmaceutical Ingredients 麻豆原创 Research Report 2023

Publication ID:

PB504235790

Publication Date:

May 15, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.

Common side effects include dizziness, headache, bruising, allergic reactions, heartburn, and stomach pain. Severe side effects include an increased risk of heart disease, stroke, gastrointestinal bleeding, and stomach ulcers. The heart disease risk may be lower than with other NSAIDs. It is not recommended in people with kidney problems. Use is not recommended in the third trimester of pregnancy.

Naproxen is a nonselective COX inhibitor. It is in the propionic acid class of medications. As an NSAID, naproxen appears to exert its anti-inflammatory action by reducing the production of inflammatory mediators called prostaglandins. It is metabolized by the liver to inactive metabolites.

Naproxen was patented in 1967, and approved for medical use in the United States in 1976. It is available over the counter and as a generic medication. In 2017, it was the 71st most commonly prescribed medication in the United States, with more than eleven million prescriptions.
The global Naproxen Active Pharmaceutical Ingredients market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Naproxen Active Pharmaceutical Ingredients is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Naproxen Active Pharmaceutical Ingredients is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Naproxen Active Pharmaceutical Ingredients include Xinhua Pharm, Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, The Perrigo Company, Taj Pharmaceuticals Ltd, LGM Pharma, Iwaki Seiyaku and Atom pharma, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Naproxen Active Pharmaceutical Ingredients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naproxen Active Pharmaceutical Ingredients.
The Naproxen Active Pharmaceutical Ingredients market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Naproxen Active Pharmaceutical Ingredients market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Naproxen Active Pharmaceutical Ingredients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
The Perrigo Company
Taj Pharmaceuticals Ltd
LGM Pharma
Iwaki Seiyaku
Atom pharma
Segment by Type
Purity (99%-99.5%)
Purity (above 99.5%)
Purity (below 99 %)
Segment by Application
Treat pain
Menstrual cramps
Inflammatory diseases
Fever
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Naproxen Active Pharmaceutical Ingredients manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Naproxen Active Pharmaceutical Ingredients by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Naproxen Active Pharmaceutical Ingredients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Naproxen Active Pharmaceutical Ingredients 麻豆原创 Overview
1.1 Product Definition
1.2 Naproxen Active Pharmaceutical Ingredients Segment by Type
1.2.1 Global Naproxen Active Pharmaceutical Ingredients 麻豆原创 Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Purity (99%-99.5%)
1.2.3 Purity (above 99.5%)
1.2.4 Purity (below 99 %)
1.3 Naproxen Active Pharmaceutical Ingredients Segment by Application
1.3.1 Global Naproxen Active Pharmaceutical Ingredients 麻豆原创 Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Treat pain
1.3.3 Menstrual cramps
1.3.4 Inflammatory diseases
1.3.5 Fever
1.3.6 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Naproxen Active Pharmaceutical Ingredients Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Naproxen Active Pharmaceutical Ingredients Production Estimates and Forecasts (2018-2029)
1.4.4 Global Naproxen Active Pharmaceutical Ingredients 麻豆原创 Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Naproxen Active Pharmaceutical Ingredients Production 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Naproxen Active Pharmaceutical Ingredients Production Value 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Key Players of Naproxen Active Pharmaceutical Ingredients, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Naproxen Active Pharmaceutical Ingredients 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Naproxen Active Pharmaceutical Ingredients Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Naproxen Active Pharmaceutical Ingredients, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Naproxen Active Pharmaceutical Ingredients, Product Offered and Application
2.8 Global Key Manufacturers of Naproxen Active Pharmaceutical Ingredients, Date of Enter into This Industry
2.9 Naproxen Active Pharmaceutical Ingredients 麻豆原创 Competitive Situation and Trends
2.9.1 Naproxen Active Pharmaceutical Ingredients 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Naproxen Active Pharmaceutical Ingredients Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Naproxen Active Pharmaceutical Ingredients Production by Region
3.1 Global Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Region (2018-2029)
3.2.1 Global Naproxen Active Pharmaceutical Ingredients Production Value 麻豆原创 Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Naproxen Active Pharmaceutical Ingredients by Region (2024-2029)
3.3 Global Naproxen Active Pharmaceutical Ingredients Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Naproxen Active Pharmaceutical Ingredients Production by Region (2018-2029)
3.4.1 Global Naproxen Active Pharmaceutical Ingredients Production 麻豆原创 Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Naproxen Active Pharmaceutical Ingredients by Region (2024-2029)
3.5 Global Naproxen Active Pharmaceutical Ingredients 麻豆原创 Price Analysis by Region (2018-2023)
3.6 Global Naproxen Active Pharmaceutical Ingredients Production and Value, Year-over-Year Growth
3.6.1 North America Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2018-2029)
4 Naproxen Active Pharmaceutical Ingredients Consumption by Region
4.1 Global Naproxen Active Pharmaceutical Ingredients Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Naproxen Active Pharmaceutical Ingredients Consumption by Region (2018-2029)
4.2.1 Global Naproxen Active Pharmaceutical Ingredients Consumption by Region (2018-2023)
4.2.2 Global Naproxen Active Pharmaceutical Ingredients Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Naproxen Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Naproxen Active Pharmaceutical Ingredients Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Naproxen Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Naproxen Active Pharmaceutical Ingredients Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Naproxen Active Pharmaceutical Ingredients Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Naproxen Active Pharmaceutical Ingredients Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Naproxen Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Naproxen Active Pharmaceutical Ingredients Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Naproxen Active Pharmaceutical Ingredients Production by Type (2018-2029)
5.1.1 Global Naproxen Active Pharmaceutical Ingredients Production by Type (2018-2023)
5.1.2 Global Naproxen Active Pharmaceutical Ingredients Production by Type (2024-2029)
5.1.3 Global Naproxen Active Pharmaceutical Ingredients Production 麻豆原创 Share by Type (2018-2029)
5.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Type (2018-2029)
5.2.1 Global Naproxen Active Pharmaceutical Ingredients Production Value by Type (2018-2023)
5.2.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Type (2024-2029)
5.2.3 Global Naproxen Active Pharmaceutical Ingredients Production Value 麻豆原创 Share by Type (2018-2029)
5.3 Global Naproxen Active Pharmaceutical Ingredients Price by Type (2018-2029)
6 Segment by Application
6.1 Global Naproxen Active Pharmaceutical Ingredients Production by Application (2018-2029)
6.1.1 Global Naproxen Active Pharmaceutical Ingredients Production by Application (2018-2023)
6.1.2 Global Naproxen Active Pharmaceutical Ingredients Production by Application (2024-2029)
6.1.3 Global Naproxen Active Pharmaceutical Ingredients Production 麻豆原创 Share by Application (2018-2029)
6.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Application (2018-2029)
6.2.1 Global Naproxen Active Pharmaceutical Ingredients Production Value by Application (2018-2023)
6.2.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Application (2024-2029)
6.2.3 Global Naproxen Active Pharmaceutical Ingredients Production Value 麻豆原创 Share by Application (2018-2029)
6.3 Global Naproxen Active Pharmaceutical Ingredients Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Xinhua Pharm
7.1.1 Xinhua Pharm Naproxen Active Pharmaceutical Ingredients Corporation Information
7.1.2 Xinhua Pharm Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.1.3 Xinhua Pharm Naproxen Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Xinhua Pharm Main Business and 麻豆原创s Served
7.1.5 Xinhua Pharm Recent Developments/Updates
7.2 Granules India Limited
7.2.1 Granules India Limited Naproxen Active Pharmaceutical Ingredients Corporation Information
7.2.2 Granules India Limited Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.2.3 Granules India Limited Naproxen Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Granules India Limited Main Business and 麻豆原创s Served
7.2.5 Granules India Limited Recent Developments/Updates
7.3 Huagang Pharm
7.3.1 Huagang Pharm Naproxen Active Pharmaceutical Ingredients Corporation Information
7.3.2 Huagang Pharm Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.3.3 Huagang Pharm Naproxen Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Huagang Pharm Main Business and 麻豆原创s Served
7.3.5 Huagang Pharm Recent Developments/Updates
7.4 Hebei Jiheng Pharmaceutical
7.4.1 Hebei Jiheng Pharmaceutical Naproxen Active Pharmaceutical Ingredients Corporation Information
7.4.2 Hebei Jiheng Pharmaceutical Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.4.3 Hebei Jiheng Pharmaceutical Naproxen Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Hebei Jiheng Pharmaceutical Main Business and 麻豆原创s Served
7.4.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
7.5 The Perrigo Company
7.5.1 The Perrigo Company Naproxen Active Pharmaceutical Ingredients Corporation Information
7.5.2 The Perrigo Company Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.5.3 The Perrigo Company Naproxen Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2018-2023)
7.5.4 The Perrigo Company Main Business and 麻豆原创s Served
7.5.5 The Perrigo Company Recent Developments/Updates
7.6 Taj Pharmaceuticals Ltd
7.6.1 Taj Pharmaceuticals Ltd Naproxen Active Pharmaceutical Ingredients Corporation Information
7.6.2 Taj Pharmaceuticals Ltd Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.6.3 Taj Pharmaceuticals Ltd Naproxen Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Taj Pharmaceuticals Ltd Main Business and 麻豆原创s Served
7.6.5 Taj Pharmaceuticals Ltd Recent Developments/Updates
7.7 LGM Pharma
7.7.1 LGM Pharma Naproxen Active Pharmaceutical Ingredients Corporation Information
7.7.2 LGM Pharma Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.7.3 LGM Pharma Naproxen Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2018-2023)
7.7.4 LGM Pharma Main Business and 麻豆原创s Served
7.7.5 LGM Pharma Recent Developments/Updates
7.8 Iwaki Seiyaku
7.8.1 Iwaki Seiyaku Naproxen Active Pharmaceutical Ingredients Corporation Information
7.8.2 Iwaki Seiyaku Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.8.3 Iwaki Seiyaku Naproxen Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Iwaki Seiyaku Main Business and 麻豆原创s Served
7.7.5 Iwaki Seiyaku Recent Developments/Updates
7.9 Atom pharma
7.9.1 Atom pharma Naproxen Active Pharmaceutical Ingredients Corporation Information
7.9.2 Atom pharma Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.9.3 Atom pharma Naproxen Active Pharmaceutical Ingredients Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Atom pharma Main Business and 麻豆原创s Served
7.9.5 Atom pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Naproxen Active Pharmaceutical Ingredients Industry Chain Analysis
8.2 Naproxen Active Pharmaceutical Ingredients Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Naproxen Active Pharmaceutical Ingredients Production Mode & Process
8.4 Naproxen Active Pharmaceutical Ingredients Sales and 麻豆原创ing
8.4.1 Naproxen Active Pharmaceutical Ingredients Sales Channels
8.4.2 Naproxen Active Pharmaceutical Ingredients Distributors
8.5 Naproxen Active Pharmaceutical Ingredients Customers
9 Naproxen Active Pharmaceutical Ingredients 麻豆原创 Dynamics
9.1 Naproxen Active Pharmaceutical Ingredients Industry Trends
9.2 Naproxen Active Pharmaceutical Ingredients 麻豆原创 Drivers
9.3 Naproxen Active Pharmaceutical Ingredients 麻豆原创 Challenges
9.4 Naproxen Active Pharmaceutical Ingredients 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
The Perrigo Company
Taj Pharmaceuticals Ltd
LGM Pharma
Iwaki Seiyaku
Atom pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.